WednesdayApr 10, 2024 2:06 pm

QualityStocksNewsBreaks – Why Life Electric Vehicles Holdings Inc. (LFEV) Is ‘One to Watch’

Life Electric Vehicles Holdings (OTC: LFEV) (d/b/a Life EV Group), together with its subsidiaries, is a developer, manufacturer and distributor in the light electric vehicle industry. Focusing on the launch, acquisition and consolidation of multiple brands of e-bikes, e-trikes, e-scooters and light EVs, the company aims to position itself as an industry leader for the American micro-mobility market “In addition to offering ready-to-ride electric vehicles, Life EV Group intends to distribute individual components, including motors, batteries, chargers, controllers and EV parts, to third-party manufacturers in both the U.S. and worldwide,” a recent article reads. “The company’s first acquisition was completed…

Continue Reading

WednesdayApr 10, 2024 1:08 pm

QualityStocksNewsBreaks – SenesTech Inc. (NASDAQ: SNES) Eyes Significant Interest Since Full Launch of Evolve(TM)

SenesTech (NASDAQ: SNES), a rodent fertility control expert and the innovator of the only EPA-registered contraceptive for male and female rats, recently released its financial results for the 2023 financial year. “Of note was the 80% year-to-date (‘YTD’) revenue growth and the 45.2% year-over-year (‘YOY’) growth in gross profit, a significant milestone which Joel Fruendt, president and CEO of SenesTech, attributed to the development of Evolve(TM), the company’s all-new soft bait product,” a recent article reads. “Since the full launch of Evolve in January 2024, we have seen a significant uptick in interest and orders from a wide range of…

Continue Reading

WednesdayApr 10, 2024 10:31 am

Golden Triangle Ventures Inc. (GTVH) Making Key Progress in Development of Destino Ranch, an Immersive Entertainment Venue

Developed under Lavish Entertainment, a wholly owned subsidiary of GTVH, Destino Ranch will be a one-of-a-kind destination that revolutionizes the concept of an immersive music and art venue. Phase one development begins after the execution of a land-use-and-development agreement outlining exclusive rights to purchase, use and operate the nearly 70-acre property. Additional upgrades on the initial property secured will “dramatically increase speed into the market.” Marco Moreno has been appointed as president of Lavish Entertainment to spearhead the development of Destino Ranch. Mr. Moreno has notable experience in the large-scale event development industry with high-fidelity collaborations through his company ABI…

Continue Reading

WednesdayApr 10, 2024 10:30 am

Podfest Masterclass Presents AI & Creator Tools Virtual Summit

Podfest Multimedia Expo’s 2024 Masterclass will provide education on A.I. & Creator Tools over April 19th, 22nd, 23rd, and 24th. Taking place online, the four-day event brings the latest technological revolution directly to attendees’ screens with case studies, How To’s, and breakout sessions with cutting edge topics. The virtual summit will benefit audio and video creators at all levels, whether beginner, intermediate, or advanced. The AI & Creator Tools program has been designed to help its attendees stay ahead of the game in content creation. Over the four days of the event, education will include sessions such as, “Teach ChatGPT…

Continue Reading

WednesdayApr 10, 2024 9:45 am

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Nutriband’s AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, like fentanyl, while keeping these drugs accessible to patients AVERSA technology can be incorporated into any transdermal patch The company has a broad intellectual property portfolio protecting AVERSA, with patents granted in the U.S., Europe, Japan, Korea, Russia, Canada, Mexico and Australia Nutriband announced in March 2024 that it will submit a New Drug Application to the FDA seeking approval to market AVERSA Fentanyl, its abuse-deterrent fentanyl transdermal patch In April 2024, the company announced it had received a contract manufacturing order from…

Continue Reading

TuesdayApr 09, 2024 3:35 pm

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Presents Key Data in First-Ever Scientific Presentation of Proprietary HeartBeam AI

HeartBeam(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, is presenting new data at the European Heart Rhythm Association (“EHRA”) Conference. According to the announcement, this is the first scientific presentation on the company’s deep learning algorithm: HeartBeam AI. The data demonstrates that applying the company’s artificial intelligence (“AI”) algorithms to vectorcardiography (“VCG”) showed considerably improved performance in the detection of atrial flutter over single-lead electrocardiograms (“ECGs”) and similar performance to 12-lead ECGs, the standard for diagnosing atrial flutter. The company noted that the data indicates an opportunity for a VCG-based algorithm…

Continue Reading

TuesdayApr 09, 2024 3:08 pm

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Featured in Bell2Bell Podcast

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Thomas Ullrich, CEO of Aston Bay, joined the program to provide an introduction to Aston Bay and its business model. “Overall, Aston Bay is in the business of adding value through discovery of high-grade critical metals and precious metals deposits,” Ullrich said in the interview. “We’re an exploration stage company. Really…

Continue Reading

TuesdayApr 09, 2024 10:30 am

Bebuzee Inc. (BBUZ) Is ‘One to Watch’

Bebuzee in November 2023 announced completion of its superapp, which combines multiple digital services into a single, user-friendly platform for the U.S. and European markets In September 2022, the company filed with the SEC for a Regulation A registration exempt public offering of up to $75 million of its common shares The company in April 2022 announced a private placement offering of up to $10 million of its common shares Bebuzee (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch…

Continue Reading

TuesdayApr 09, 2024 9:45 am

SenesTech Inc. (NASDAQ: SNES) Inks Distribution Agreement with Wilco Distributors for Evolve(TM) Soft Bait

SenesTech, a company that offers fertility control products for rodent pests, launched Evolve(TM) Soft Bait in October 2023, and has so far inked multiple distribution agreements as part of its multi-prong go-to-market strategy for the product The company recently announced it had signed a distribution agreement with Wilco Distributors Inc., a Glendale, Arizona-based distributor of pest management baits and tools to the rodent pest management market In addition to Evolve, SenesTech also offers ContraPest(R), a highly palatable professional-grade contraceptive liquid formulation for both male and female rats Evolve and ContraPest are positioned as effective non-lethal alternatives to registered rodenticides that…

Continue Reading

TuesdayApr 09, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) has Emerged as a Leader in the Neurodegenerative Field Utilizing a Novel Nanotherapeutic Drug

Clinical trials of Clene’s lead candidate CNM-Au8(R) have shown notable success in crossing the blood-brain barrier and enhancing the brain's bioenergetic metabolites, essentially "reversing the clock" on what would be considered healthy aging CNM-Au8 has shown promise in clinical trials for both ALS and MS, including improvements in survival rates and clinical function Clene was recently featured in an interview of CEO Rob Etherington on ‘First in Human’ podcast In a significant advancement for the treatment of neurodegenerative diseases, Clene (NASDAQ: CLNN) has innovated CNM-Au8, an oral nanotherapeutic designed to revitalize the brain's mitochondrial function. The potential of this drug…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered